Eligibility for lipid-lowering randomised clinical trials and long-term outcomes in real-world contemporary patients with atherosclerotic cardiovascular disease
Elevated triglycerides are related to higher residual cardiovascular disease and mortality risk independent of lipid targets and lipid-lowering therapy intensity in cardiovascular disease patients
